山东大学学报 (医学版) ›› 2026, Vol. 64 ›› Issue (8): 64-70.doi: 10.6040/j.issn.1671-7554.0.2026.0665
• 临床医学 • 上一篇
丁文静1,杨一帆1,胡忻雨1,爱丽菲拉·艾力1,张昊芃1,薛新颖2,潘磊1
DING Wenjing1, YANG Yifan1, HU Xinyu1, AILI Ailifeila1, ZHANG Haopeng1, XUE Xinying2, PAN Lei1
摘要: 目的 探讨急进高原人群急性高原病(acute mountain sickness, AMS)发生相关因素及高原暴露前后生理参数变化特征。 方法 纳入2024年在西藏地区招募并完成高原暴露前后资料采集的男性受试者101例,根据高原暴露后路易斯湖评分分为非AMS组(n=59)和AMS组(n=42)。收集两组人口学资料、危险因素及高原暴露前后外周血氧饱和度(peripheral oxygen saturation, SpO2)、心率、血压、平均动脉压(mean arterial pressure, MAP)和心率血压乘积(rate pressure product, RPP)等指标,比较两组差异,并采用logistic回归分析AMS发生相关因素。 结果 高原暴露后,两组SpO2显著下降,心率、收缩压、MAP和RPP升高(P<0.05)。高原暴露前,AMS组与非AMS组静息生理指标差异均无统计学意义(P>0.05),但AMS组首次进入高原、吸烟史和饮酒史比例高于非AMS组(P<0.05)。高原暴露后,AMS组SpO2低于非AMS组,收缩压、舒张压和RPP高于非AMS组(P<0.05)。变化值比较显示,AMS组SpO2下降幅度大于非AMS组(P=0.01)。多因素logistic回归分析显示,首次进入高原与AMS发生呈相关性(OR=5.42,95%CI:1.80~16.29,P=0.003)。 结论 急进高原后人群出现明显氧合下降和心血管代偿增强。高原暴露前常规静息生理指标难以区分AMS和非AMS,首次进入高原是AMS发生的重要相关因素;SpO2下降幅度和RPP升高可作为高原暴露后AMS现场识别与分层管理的参考指标。
中图分类号:
| [1] Roach R C, Bärtsch P, Hackett P H, et al. The Lake Louise acute mountain sickness scoring system[M] //Sutton J R, Houston C S, Coates G. Hypoxia and Molecular Medicine. Burlington, VT: Queen City Press, 1993: 272-274. [2] Luks A M, Beidleman B A, Freer L, et al. Wilderness Medical Society clinical practice guidelines for the prevention, diagnosis, and treatment of acute altitude illness: 2024 update[J]. Wilderness Environ Med, 2024, 35(S1): 2-19. [3] Luks A M, Swenson E R, Bärtsch P. Acute high-altitude sickness[J]. Eur Respir Rev, 2017, 26(143): 160096. DOI:10.1183/16000617.0096-2016 [4] Hackett P H, Roach R C. High-altitude illness[J]. N Engl J Med, 2001, 345(2): 107-114. [5] Bärtsch P, Swenson E R. Clinical practice: acute high-altitude illnesses[J]. N Engl J Med, 2013, 368(24): 2294-2302. [6] Burtscher M, Hefti U, Hefti J P. High-altitude illnesses: old stories and new insights into the pathophysiology, treatment and prevention[J]. Sports Med Health Sci, 2021, 3(2): 59-69. [7] Wang B Y, Chen S J, Song J F, et al. Recent advances in predicting acute mountain sickness: from multidimensional cohort studies to cutting-edge model applications[J]. Front Physiol, 2024, 15: 1397280. DOI:10.3389/fphys.2024.1397280 [8] Imray C, Wright A, Subudhi A, et al. Acute mountain sickness: pathophysiology, prevention, and treatment[J]. Prog Cardiovasc Dis, 2010, 52(6): 467-484. [9] 汤秋彤, 李芙兰, 谢海霞, 等. 高原病发病率及其影响因素的系统评价[J]. 山东医药, 2025, 65(11): 76-81. Tang Qiutong, Li Fulan, Xie Haixia, et al. Systematic review of the incidence and riskfactors of high-altitude sickness[J]. Shandong Medical Journal, 2025, 65(11): 76-81. [10] Cobb A B, Levett D Z H, Mitchell K, et al. Physiological responses during ascent to high altitude and the incidence of acute mountain sickness[J]. Physiol Rep, 2021, 9(7): e14809. DOI:10.14814/phy2.14809 [11] Horiuchi M, Mitsui S, Uno T. Influence of smoking and alcohol habits on symptoms of acute mountain sickness on Mount Fuji: a questionnaire survey-based pilot study[J]. High Alt Med Biol, 2024, 25(2): 140-148. [12] 郭马特, 陈强, 姬冬冬, 等. 健康人群在急进高原后心功能指标变化的观察研究和分析[J]. 中国循证心血管医学杂志, 2025, 17(4): 486-489. Guo Mate, Chen Qiang, Ji Dongdong, et al. Changes of heart function indexes in healthy people after rapid ascent to plateau[J]. Chinese Journal of Evidence-Based Cardiovascular Medicine, 2025, 17(4): 486-489. [13] 李佳, 李霞, 戚海兰, 等. 人工智能在急性高原病早期预警监测中的进展[J]. 中国心血管病研究, 2026, 24(1): 84-90. Li Jia, Li Xia, Qi Hailan, et al. Advances in artificial intelligence for earlywarning and monitoring of acute mountain sickness[J]. Chinese Journal of Cardiovascular Research, 2026, 24(1): 84-90. [14] Yang J, Jia Z L, Song X Y, et al. Proteomic and clinical biomarkers for acute mountain sickness in a longitudinal cohort[J]. Commun Biol, 2022,5(1): 548. DOI:10.1038/s42003-022-03514-6 [15] Joyce K E, Ashdown K, Delamere J P, et al. Nocturnal pulse oximetry for the detection and prediction of acute mountain sickness: an observational study[J]. Exp Physiol, 2024, 109(11): 1856-1868. [16] Li W H, Zhang M, Hu Y Y, et al. Acute mountain sickness prediction: a concerto of multidimensional phenotypic data and machine learning strategies in the framework of predictive, preventive, and personalized medicine[J]. EPMA J, 2025, 16(2): 265-284. [17] Chen R Z, Sun M J, Yang J, et al. Cardiovascular indicators of systemic circulation and acute mountain sickness: an observational cohort study[J]. Front Physiol, 2021, 12: 708862. DOI:10.3389/fphys.2021.708862 [18] Goves J S L, Joyce K E, Broughton S, et al. Pulse oximetry for the prediction of acute mountain sickness: a systematic review[J].Exp Physiol, 2024,109(12):2057-2072. [19] 刘阳, 张继航, 武晓静, 等. 高原暴露人群动脉血压变化与急性高原病的相关性分析[J]. 解放军医学杂志, 2014, 39(3): 226-230. Liu Yang, Zhang Jihang, Wu Xiaojing, et al. Correlation analysis of the changes inarterial blood pressure in people with acute mountain sickness when exposed to high altitude[J].Medical Journal of Chinese Peoples Liberation Army, 2014, 39(3): 226-230. [20] Gatterer H, Villafuerte F C, Ulrich S, et al. Altitude illnesses[J]. Nat Rev Dis Primers, 2024, 10(1): 43. DOI:10.1038/s41572-024-00526-w [21] Lanfranchi P A, Colombo R, Cremona G, et al. Autonomic cardiovascular regulation in subjects with acute mountain sickness[J]. Am J Physiol Heart Circ Physiol, 2005, 289(6): 2364-2372. [22] Cai C M, Ni G H, Chen L, et al. Altitude hypoxia and hypoxemia: pathogenesis and management[J].Signal Transduct Target Ther, 2026,1(1): 27. DOI:10.1038/s41392-025-02531-1 [23] Sutherland A, Freer J, Evans L, et al. MEDEX 2015: heart rate variability predicts development of acute mountain sickness[J]. High Alt Med Biol, 2017,18(3): 199-208. [24] Ke J B, Yang J, Liu C, et al. A novel echocardiographic parameter to identify individuals susceptible to acute mountain sickness[J]. Travel Med Infect Dis, 2021, 44: 102166. DOI:10.1016/j.tmaid.2021.102166 [25] Ye X W, Sun M J, Yu S Y, et al. Smartwatch-based maximum oxygen consumption measurement for predicting acute mountain sickness: diagnostic accuracy evaluation study[J]. JMIR Mhealth Uhealth, 2023, 11: e43340. DOI:10.2196/43340 [26] Small E, Juul N, Pomeranz D, et al. Predictive capacity of pulmonary function tests for acute mountain sickness[J]. High Alt Med Biol, 2021, 22(2): 193-200. [27] Yang J, Jia Z L, Song X Y, et al. Proteomic and clinical biomarkers for acute mountain sickness in a longitudinal cohort[J]. Commun Biol, 2022, 5(1): 548. DOI:10.1038/s42003-022-03514-6 [28] Yang M, Wu Y, Yang X B, et al. Establishing a prediction model of severe acute mountain sickness using machine learning of support vector machine recursive feature elimination[J]. Sci Rep, 2023, 13(1): 4633. DOI:10.1038/s41598-023-31797-0 [29] Li Y, Ma Y Y, Wang K, et al. Using composite phenotypes to reveal hidden physiological heterogeneity in high-altitude acclimatization in a Chinese Han longitudinal cohort[J]. Phenomics, 2021, 1(1): 3-14. [30] Richalet J P, Hermand E, Lhuissier F J. Cardiovascular physiology and pathophysiology at high altitude[J]. Nat Rev Cardiol, 2024, 21(2): 75-88. [31] 李彬, 李年华, 高亮, 等. 急慢性高原反应症状体征影响因素及相关性探讨[J]. 西北国防医学杂志, 2016, 37(8): 494-496. Li Bin, Li Nianhua, Gao Liang, et al. Influential factors and its correlation of signs andsymptoms of acute and chronic high altitude reaction[J]. Medical Journal of National Defending Forces in Northwest China, 2016, 37(8): 494-496. [32] Muza S R. Wearable physiological sensors and real-time algorithms for detection of acute mountain sickness[J]. J Appl Physiol(1985), 2018, 124(3): 557-563. [33] Zeng Z Y, Li L L, Hu L A, et al.Smartwatch measurement of blood oxygen saturation for predicting acute mountain sickness: diagnostic accuracy and reliability[J]. Digit Health, 2024, 10: 20552076241284910. DOI:10.1177/20552076241284910 |
| [1] | 陈功海,曲春媚,谢雪雪,王刚,赵连晖,赛林涛,许楠楠. 布病脊柱炎的临床特征及危险因素[J]. 山东大学学报 (医学版), 2026, 64(8): 1-7. |
| [2] | 吕高钰,薛美娟,徐俊杰,刘亚楠,张晴阳,侯明,石艳. 初诊老年不适合强化疗急性髓系白血病维奈克拉联合阿扎胞苷治疗后血液学恢复不良的危险因素[J]. 山东大学学报 (医学版), 2026, 64(8): 56-63. |
| [3] | 薛宁,魏绪霞,徐俊杰,唐运萍,杨露. 不同年龄组儿童艰难梭菌感染临床特点及预后影响因素[J]. 山东大学学报 (医学版), 2026, 64(7): 55-62. |
| [4] | 黄玉真,吕琛,颜磊,李帅帅,张景雪,刘超,王银霞,桑岩岩,房鹛. 基于危险因素筛查的延续性院外管理对卵巢过度刺激综合征的预防效果[J]. 山东大学学报 (医学版), 2026, 64(4): 92-99. |
| [5] | 逄锦宏,苏萍,乔俊鹏,陈巧巧,陈学禹,赵颖颖,施婕,孙晓茹,李秋春,何蕊言,范轶欧,迟蔚蔚. 老年人群可改变心血管危险因素聚集模式与脑卒中的关联[J]. 山东大学学报 (医学版), 2025, 63(9): 11-19. |
| [6] | 张政,王建伟,杨玉娟,张宇,宋西成. 哮喘儿童2008及2019年免疫球蛋白E变化及相关危险因素[J]. 山东大学学报 (医学版), 2025, 63(7): 32-36. |
| [7] | 李敬,郝盼盼. 急性心力衰竭患者出入院心率变化与预后相关性[J]. 山东大学学报 (医学版), 2025, 63(4): 75-82. |
| [8] | 程震宇,来庆国,吴梦涛. 髂股静脉支架置入术后再狭窄的影响因素研究进展[J]. 山东大学学报 (医学版), 2025, 63(12): 112-117. |
| [9] | 程跃启,王斐,于理想,郑超,余之刚. 曲妥珠单抗致HER2阳性乳腺癌患者心脏毒性的研究进展[J]. 山东大学学报 (医学版), 2025, 63(1): 17-24. |
| [10] | 王浙宇,许懿,赵昌波,杨硕菲,倪其泓,陈佳佺,王韦仑,李一男,郭相江,叶猛,张岚,薛冠华. 腹主动脉瘤腔内修复术后发生髂支闭塞的危险因素及处理对策[J]. 山东大学学报 (医学版), 2024, 62(9): 101-107. |
| [11] | 郭鑫,孟君,郑世良,董秀红. 老年胃癌患者衰弱与人体成分的相关性[J]. 山东大学学报 (医学版), 2024, 62(4): 40-47. |
| [12] | 李建,孙云. 新入维持性血液透析患者2年内死亡的危险因素[J]. 山东大学学报 (医学版), 2024, 62(4): 48-53. |
| [13] | 宋甜田,李作坤,王书会. 个体化预测老年心脏瓣膜置换术后医院感染风险Nomogram模型的构建[J]. 山东大学学报 (医学版), 2024, 62(1): 48-56. |
| [14] | 曲永强,赵泽宇,吴兴原,韩玮,段瑞生,李衍滨,李亨. 颈动脉分叉处支架置入术后严重持续性低血压的危险因素[J]. 山东大学学报 (医学版), 2023, 61(7): 78-82. |
| [15] | 宋晗,王振华,韦铎亮,徐凯,李博文,赵鑫. 术前MELD分级对304例急性StandfordA型主动脉夹层患者术后早期结局的影响[J]. 山东大学学报 (医学版), 2023, 61(5): 31-36. |
|
||